PR Newswire: news distribution, targeting and monitoring
 

China Botanic Schedules Conference Call to Discuss Fourth Quarter and Fiscal Year 2011 Results

 

HARBIN, China, Jan. 30, 2012 /PRNewswire-Asia/ -- China Botanic Pharmaceutical Inc. (AMEX: CBP) ("China Botanic" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced that it will host a conference call at 9:00 a.m. Eastern Time on Tuesday, January 31, 2012, to discuss financial results for the fourth quarter and fiscal year 2011 ended October 31, 2011.

Joining Mr. Shaoming Li, China Botanic's chairman and CEO, will be Mr. Guangtao Li, the Company's vice president and Mr. David Dong, the Company's CFO.

To participate in the conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: 866-394-2209. International callers should dial 706-758-1481. The conference ID number for the call is 46104402.

If you are unable to participate in the call at this time, a replay will be available on Tuesday, January 31, 2012 at 11:00 am Eastern Time, through Thursday, February 11, 2012. To access the replay, dial 855-859-2056. International callers should dial 404-537-3406. The conference ID number for the replay is 46104402.

ABOUT CHINA BOTANIC PHARMACEUTICAL INC.

China Botanic Pharmaceutical Inc. is engaged in the research, development, manufacturing, and distribution of botanical products, bio-pharmaceutical products, and traditional Chinese medicines ("TCM"), in the People's Republic of China.  All of the Company's products are produced at its three GMP-certified production facilities in Ah City, Dongfanghong and Qingyang. The Company distributes its botanical anti-depression and nerve-regulation products, biopharmaceutical products, and botanical antibiotic and OTC TCMs through its network of over 3,000 distributors and over 70 sales centers across 24 provinces in China.

Company Contact:                                                       CCG Investor Relations:


China Botanic Pharmaceutical Inc.                               Mr. Mark Collinson, Partner
Ms. Portia Tan, IR Contact                                           Phone: +1-310-954-1343 (Los Angeles)
Tel: 86-451-8260-2162                                                 Email: mark.collinson@ccgir.com
Email: ir@renhuang.com                                             Website: www.ccgirasia.com

                                                                                 Mr. Crocker Coulson, President
                                                                                 Phone: +1-646-213-1915 (New York)
                                                                                 Email: crocker.coulson@ccgir.com

SOURCE China Botanic Pharmaceutical Inc.

Back to top

RELATED LINKS
http://www.renhuang.com
http://www.ccgirasia.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.

Featured Video

 
  • Print
  • Email
  •   RSS
  • Share it  
  • Blog it  
  • Blog Search  

Journalists and Bloggers

Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.

View and download archived video content distributed by MultiVu on The Digital Center.

Free Investing Newsletter from Investor Uprising!

Learn to navigate the world's financial system and profit from leading companies.  

Register for Investor Uprising, the people's investment site, for a free weekly newsletter, information, education and premium research including our latest IU Confidential Report - "All That Glitters: The Ultimate Gold Report".

Advanced Search
Search
  
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire